LifeVantage is a direct-selling wellness company that makes and sells dietary supplements and skin care products through a network of roughly 51,000 independent consultants and its own website. The company's core concept is "nutrigenomics" — using natural compounds to activate gene pathways in the body rather than directly supplementing nutrients. Its flagship product, Protandim Nrf2 Synergizer, activates the Nrf2 pathway to stimulate the body's own antioxidant enzyme production. Its newest and fastest-growing product, MindBody GLP-1 System, is positioned as a natural, non-pharmaceutical alternative to GLP-1 drugs like Ozempic, claiming to activate the body's own GLP-1 hormone production. The U.S. accounts for roughly 78% of revenue, with Japan the second-largest market. LifeVantage operates through a multi-level marketing structure, paying consultants commissions on their own sales and those of their recruits, with commission expense running roughly 42-48% of revenue. Gross margins are high, and roughly 70-85% of revenue comes through recurring monthly subscriptions. The company outsources manufacturing and logistics, keeping its headcount lean. Growth strategy centers on the ongoing global rollout of MindBody, a pending acquisition of LoveBiome (a microbiome-focused direct-selling company), and digital infrastructure upgrades via a Shopify partnership. LifeVantage carries no debt and returns capital to shareholders through dividends and buybacks.